Showing results (31-40 of 150) with videos related to

Sort By:
Pageof 15
Journal of Diabetes and Metabolic Disorders|October 16, 2025
Insulin-like growth factor (IGF) and Insulin-like growth factor binding proteins (IGFBP) as predictors of type 2 diabetes risk in obese adultsPriyanshi Maurya, Jun Yang, Allan Barnes, et al.
Journal of the American Heart Association|August 10, 2022
Perioperative Metabolites Are Associated With Adverse Neonatal Congenital Heart Disease Surgical OutcomesJessica Heibel, Eric M Graham, William T Mahle, et al.
Hepatology (Baltimore, Md.)|November 26, 2002
Hepatoma-derived growth factor is highly expressed in developing liver and promotes fetal hepatocyte proliferationHirayuki Enomoto, Kenya Yoshida, Yoshihiko Kishima, et al.
Pediatric Research|November 16, 2024
Longitudinal analysis of urinary I-FABP in extremely preterm infants that develop necrotizing enterocolitisJennifer B Fundora, Darla R Shores, Allen D Everett, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|August 7, 2010
Percutaneous closure of patent ductus arteriosus: a multiinstitutional registry comparing multiple devicesMarissa A Brunetti, Richard Ringel, Carl Owada, et al.
Plos One|October 8, 2016
Risk Factors and Clinical Outcomes in Preterm Infants with Pulmonary HypertensionJoseph M Collaco, Gul H Dadlani, Melanie K Nies, et al.
Critical Care Medicine|June 18, 2015
Plasma Biomarkers of Brain Injury as Diagnostic Tools and Outcome Predictors After Extracorporeal Membrane OxygenationMelania M Bembea, Nicole Rizkalla, James Freedy, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association|October 7, 2020
Blood biomarkers for neonatal hypoxic-ischemic encephalopathy in the presence and absence of sentinel eventsEric K Broni, Ahizechukwu C Eke, Dhananjay Vaidya, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 18, 2004
Expression of hepatoma-derived growth factor is a strong prognostic predictor for patients with early-stage non-small-cell lung cancerHening Ren, Ximing Tang, J Jack Lee, et al.
Pageof 15